Security
Johnson & Johnson · JNJ
JNJNYSECommon stockCurrentCIK 200406Updated Oct 14, 2026
Name history
JOHNSON & JOHNSON ET AL · through Jan 23, 1996
JNJ price & chart
Loading TradingView…
NYSE:JNJ on TradingView ↗About the company
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/.
In the news
NeOnc among Names with 2026 Breakthroughs that Offer New Hope in the Fight Against Cancer ↗
CNS Drug Delivery Technologies Are Reshaping Alzheimer’s and Biodefense Research ↗
Johnson & Johnson unveils new data showing nipocalimab is the first and only investigational FcRn blocker with potential to reduce systemic lupus erythematosus (SLE) activity in a Phase 2 study News provided by Johnson & Johnson Jan 06, 2026, 08:03 ET Share this article Share to X Share this article ↗
Recent filings
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2021 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 199,210,000,000Source | 180,104,000,000Source | 167,558,000,000Source | 182,018,000,000Source |
| Property, Plant and Equipment, NetUSD | 23,169,000,000Source | 20,518,000,000Source | 19,898,000,000Source | 18,962,000,000Source |
| GoodwillUSD | 48,772,000,000Source | 44,200,000,000Source | 36,558,000,000Source | 35,246,000,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 50,403,000,000Source | 37,618,000,000Source | 34,175,000,000Source | 46,392,000,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 19,709,000,000Source | 24,105,000,000Source | 21,859,000,000Source | 14,487,000,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 17,178,000,000Source | 14,842,000,000Source | 14,873,000,000Source | 15,283,000,000Source |
| Inventory, NetUSD | 14,191,000,000Source | 12,444,000,000Source | 11,181,000,000Source | 10,387,000,000Source |
| Assets, CurrentUSD | 55,624,000,000Source | 55,893,000,000Source | 53,495,000,000Source | 60,979,000,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 4,153,000,000Source | 4,085,000,000Source | 4,514,000,000Source | 3,701,000,000Source |
| Operating Lease, Right-of-Use AssetUSD | 1,300,000,000Source | 1,100,000,000Source | 1,000,000,000Source | 900,000,000Source |
| Other Assets, NoncurrentUSD | 14,368,000,000Source | 11,414,000,000Source | 14,153,000,000Source | 10,216,000,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 117,666,000,000Source | 108,614,000,000Source | 98,784,000,000Source | 107,995,000,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 3,120,000,000Source | 3,120,000,000Source | 3,120,000,000Source | 3,120,000,000Source |
| Retained Earnings (Accumulated Deficit)USD | 168,978,000,000Source | 155,791,000,000Source | 153,843,000,000Source | 123,060,000,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -14,930,000,000Source | -11,741,000,000Source | -12,527,000,000Source | -13,058,000,000Source |
| Liabilities and EquityUSD | 199,210,000,000Source | 180,104,000,000Source | 167,558,000,000Source | 182,018,000,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 54,126,000,000Source | 50,321,000,000Source | 46,282,000,000Source | 45,226,000,000Source |
| Accounts Payable, CurrentUSD | 11,991,000,000Source | 10,311,000,000Source | 9,632,000,000Source | 11,055,000,000Source |
| Deferred Income Tax Liabilities, NetUSD | 6,791,000,000Source | 2,448,000,000Source | 3,193,000,000Source | 7,487,000,000Source |
| Other Liabilities, NoncurrentUSD | 9,868,000,000Source | 17,549,000,000Source | 13,398,000,000Source | 10,686,000,000Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 8,594,000,000Source | 8,549,000,000Source | 10,212,000,000Source | 13,612,000,000Source |
| Deferred Tax Liabilities, NetUSD | 12,547,000,000Source | 7,175,000,000Source | 6,584,000,000Source | 9,888,000,000Source |
| Long-term Debt, Excluding Current Maturities | — | — | — | — |
| Long-term Debt, Current MaturitiesUSD | 2,000,000,000Source | 1,749,000,000Source | 1,469,000,000Source | 2,131,000,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | 39,438,000,000Source | 30,651,000,000Source | 25,881,000,000Source | 29,985,000,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2021 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 7,503,000,000Source | 7,339,000,000Source | 7,486,000,000Source | 7,390,000,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 1,354,000,000Source | 1,176,000,000Source | 1,162,000,000Source | 1,135,000,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 1,781,000,000Source | 406,000,000Source | 624,000,000Source | 2,402,000,000Source |
| Increase (Decrease) in InventoriesUSD | 1,450,000,000Source | 1,128,000,000Source | 1,323,000,000Source | 1,248,000,000Source |
| Deferred Income Tax Expense (Benefit)USD | 1,538,000,000Source | -2,183,000,000Source | -4,194,000,000Source | -2,079,000,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 24,530,000,000Source | 24,266,000,000Source | 22,791,000,000Source | 23,410,000,000Source |
| Cash flows from investing activities: | ||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | 17,541,000,000Source | 15,146,000,000Source | 0Source | 60,000,000Source |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -23,588,000,000Source | -18,599,000,000Source | 878,000,000Source | -8,683,000,000Source |
| Payments for (Proceeds from) Other Investing ActivitiesUSD | 162,000,000Source | 174,000,000Source | -12,000,000Source | 508,000,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 4,832,000,000Source | 4,424,000,000Source | 4,543,000,000Source | 3,652,000,000Source |
| Cash flows from financing activities: | ||||
| Payments for Repurchase of Common StockUSD | 5,953,000,000Source | 2,432,000,000Source | 5,054,000,000Source | 3,456,000,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -5,539,000,000Source | -3,132,000,000Source | -15,825,000,000Source | -14,047,000,000Source |
| Proceeds from (Payments for) Other Financing ActivitiesUSD | -34,000,000Source | -38,000,000Source | -269,000,000Source | 114,000,000Source |
| Repayments of Long-term DebtUSD | 1,757,000,000Source | 1,453,000,000Source | 1,551,000,000Source | 1,802,000,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -4,396,000,000Source | 2,246,000,000Source | 7,732,000,000Source | 502,000,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 19,709,000,000Source | 24,105,000,000Source | 21,859,000,000Source | 14,487,000,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 1,863,000,000Source | 1,911,000,000Source | 1,766,000,000Source | 941,000,000Source |
| Income Taxes Paid, NetUSD | 6,539,000,000Source | — | — | — |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 201,000,000Source | -289,000,000Source | -112,000,000Source | -178,000,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 1,400,000,000Source | 1,176,000,000Source | 1,087,000,000Source | 1,135,000,000Source |
| Amortization of Intangible AssetsUSD | 4,600,000,000Source | 4,500,000,000Source | 4,500,000,000Source | 4,700,000,000Source |
| Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of TaxUSD | 0Source | 0Source | 20,984,000,000Source | — |
| Equity Securities, FV-NI, Gain (Loss)USD | — | -400,000,000Source | -400,000,000Source | — |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | -254,000,000Source | -214,000,000Source | -366,000,000Source | -236,000,000Source |
| Gain (Loss) on Sale of Assets and Asset Impairment ChargesUSD | 263,000,000Source | 226,000,000Source | 117,000,000Source | 617,000,000Source |
| Gain (Loss) Related to Litigation SettlementUSD | — | — | 100,000,000Source | — |
| GoodwillUSD | 48,772,000,000Source | 44,200,000,000Source | 36,558,000,000Source | 35,246,000,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | 26,804,000,000Source | 14,066,000,000Source | 13,326,000,000Source | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to ParentUSD | 0Source | 0Source | 21,827,000,000Source | — |
| Income Tax Expense (Benefit)USD | 5,777,000,000Source | 2,621,000,000Source | 1,736,000,000Source | 1,898,000,000Source |
| InterestExpenseNonoperatingUSD | 971,000,000Source | 755,000,000Source | — | — |
| Investment Income, InterestUSD | 1,056,000,000Source | 1,332,000,000Source | 1,261,000,000Source | 53,000,000Source |
| Net Income (Loss) Attributable to ParentUSD | 26,804,000,000Source | 14,066,000,000Source | 35,153,000,000Source | 20,878,000,000Source |
| Other Nonoperating Income (Expense)USD | 7,209,000,000Source | -4,694,000,000Source | -6,634,000,000Source | -489,000,000Source |
| Payments to Acquire InvestmentsUSD | 920,000,000Source | 1,726,000,000Source | 10,906,000,000Source | 30,394,000,000Source |
| Proceeds from Issuance of Long-term DebtUSD | 9,138,000,000Source | 6,660,000,000Source | 0Source | 5,000,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2021 |
|---|---|---|---|---|
| Total RevenueUSD | 94,193,000,000Source | 88,821,000,000Source | 85,159,000,000Source | 93,775,000,000Source |
| Cost of RevenueUSD | 30,256,000,000Source | 27,471,000,000Source | 26,553,000,000Source | 29,855,000,000Source |
| Selling, General and Administrative ExpenseUSD | 23,676,000,000Source | 22,869,000,000Source | 21,512,000,000Source | 24,659,000,000Source |
| Other Nonoperating Income (Expense)USD | 7,209,000,000Source | -4,694,000,000Source | -6,634,000,000Source | -489,000,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | 32,581,000,000Source | 16,687,000,000Source | 15,062,000,000Source | 22,776,000,000Source |
| Income Tax Expense (Benefit)USD | 5,777,000,000Source | 2,621,000,000Source | 1,736,000,000Source | 1,898,000,000Source |
| Net Income (Loss) Attributable to ParentUSD | 26,804,000,000Source | 14,066,000,000Source | 35,153,000,000Source | 20,878,000,000Source |
| Earnings Per Share, BasicUSD per share | 11.13Source | 5.84Source | 13.88Source | 7.93Source |
| Earnings Per Share, DilutedUSD per share | 11.03Source | 5.79Source | 13.72Source | 7.81Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 2,407,400,000Source | 2,407,300,000Source | 2,533,500,000Source | 2,632,100,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 2,429,400,000Source | 2,429,400,000Source | 2,560,400,000Source | 2,674,000,000Source |
| Interest Expense (non-operating)USD | 971,000,000Source | 755,000,000Source | — | — |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 4,600,000,000Source | 4,500,000,000Source | 4,500,000,000Source | 4,700,000,000Source |
| Current Income Tax Expense (Benefit)USD | 4,239,000,000Source | 4,804,000,000Source | 5,795,000,000Source | 3,977,000,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | -254,000,000Source | -214,000,000Source | -366,000,000Source | -236,000,000Source |
| Gain (Loss) Related to Litigation SettlementUSD | — | — | 100,000,000Source | — |
| Gross ProfitUSD | 63,937,000,000Source | 61,350,000,000Source | 58,606,000,000Source | 63,920,000,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | 26,804,000,000Source | 14,066,000,000Source | 13,326,000,000Source | — |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | 15,254,000,000Source | -458,000,000Source | -2,033,000,000Source | 6,110,000,000Source |
| Income (Loss) from Continuing Operations, Per Basic ShareUSD per share | 11.13Source | 5.84Source | 5.26Source | — |
| Income (Loss) from Continuing Operations, Per Diluted ShareUSD per share | 11.03Source | 5.79Source | 5.2Source | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to ParentUSD | 0Source | 0Source | 21,827,000,000Source | — |
| Interest ExpenseUSD | — | — | 772,000,000Source | 183,000,000Source |
| Investment Income, InterestUSD | 1,056,000,000Source | 1,332,000,000Source | 1,261,000,000Source | 53,000,000Source |
| Research and Development ExpenseUSD | 109,000,000Source | 1,841,000,000Source | 483,000,000Source | — |
Offerings
Registration 333-293395
Filing attachments
ex991-pressrelease.htm · 8-K · 2025-06-10
EX-99 2 ex991-pressrelease.htm EX-99 Document Exhibit 99.1 Media contact: Investor contact: media-relations@its.jnj.com investor-relations@its.jnj.com FOR IMMEDIATE RELEASE Johnson & Johnson Elects Daniel Pinto, President, JPMorganChase to its Board of Directors New Brunswick, New Jersey (June 10, 2025) - Johnson & Johnson (NYSE: JNJ) announced today that Daniel Pinto, President, JPMorganChase, has been elected to its Board …
Read attachment ↗d863514dex41.htm · 8-K · 2025-02-26
EX-4.1 3 d863514dex41.htm EX-4.1 EX-4.1 Exhibit 4.1 JOHNSON & JOHNSON COMPANY ORDER Pursuant to the authorization of the Board of Directors of Johnson & Johnson, a New Jersey corporation (the “Company”), in resolutions adopted on February 14, 2023, October 31, 2022 and April 25, 2024, the undersigned, being duly authorized, hereby approves the issuance of each of the series of Notes (as defined herein) of the Company, with the terms and provisions as described below, pursuant to and furt…
Read attachment ↗d863514dex42.htm · 8-K · 2025-02-26
EX-4.2 4 d863514dex42.htm EX-4.2 EX-4.2 Exhibit 4.2 CUSIP NO.: 478160 DB7 PRINCIPAL AMOUNT ISIN: XS3005214104 €[ ] Common Code: 300521410 REGISTERED NO. R- JOHNSON & JOHNSON 2.700% NOTE DUE 2029 Unless this certificate is presented by an authorized representative of Euroclear Bank S.A./N.V. (“Euroclear”) or Clearstream Banking, Societe Anonyme (“Clearstream”) to the Company or its agent for registration of transfer, exchange or payment, and any certificate issu…
Read attachment ↗d863514dex43.htm · 8-K · 2025-02-26
EX-4.3 5 d863514dex43.htm EX-4.3 EX-4.3 Exhibit 4.3 CUSIP NO.: 478160 DC5 PRINCIPAL AMOUNT ISIN: XS3005214369 €[ ] Common Code: 300521436 REGISTERED NO. R- JOHNSON & JOHNSON 3.050% NOTE DUE 2033 Unless this certificate is presented by an authorized representative of Euroclear Bank S.A./N.V. (“Euroclear”) or Clearstream Banking, Societe Anonyme (“Clearstream”) to the Company or its agent for registration of transfer, exchange or payment, and any certificate issu…
Read attachment ↗d863514dex44.htm · 8-K · 2025-02-26
EX-4.4 6 d863514dex44.htm EX-4.4 EX-4.4 Exhibit 4.4 CUSIP NO.: 478160 DD3 PRINCIPAL AMOUNT ISIN: XS3005214799 €[ ] Common Code: 300521479 REGISTERED NO. R- JOHNSON & JOHNSON 3.350% NOTE DUE 2037 Unless this certificate is presented by an authorized representative of Euroclear Bank S.A./N.V. (“Euroclear”) or Clearstream Banking, Societe Anonyme (“Clearstream”) to the Company or its agent for registration of transfer, exchange or payment, and any certificate issu…
Read attachment ↗d863514dex45.htm · 8-K · 2025-02-26
EX-4.5 7 d863514dex45.htm EX-4.5 EX-4.5 Exhibit 4.5 CUSIP NO.: 478160 DE1 PRINCIPAL AMOUNT ISIN: XS3005215093 €[ ] Common Code: 300521509 REGISTERED NO. R- JOHNSON & JOHNSON 3.600% NOTE DUE 2045 Unless this certificate is presented by an authorized representative of Euroclear Bank S.A./N.V. (“Euroclear”) or Clearstream Banking, Societe Anonyme (“Clearstream”) to the Company or its agent for registration of transfer, exchange or payment, and any certificate issu…
Read attachment ↗